0 followers
Urovant Sciences, innovations in urology. Our lead therapeutic candidate is vibegron (RVT-901), an investigational oral β3-adrenergic agonist
James Robinson
Cellphire Therapeutics
3 followers
Entos
1 follower
Thermo Fisher Scientific
166 followers
Regeneron
94 followers
Agilent Technologies
63 followers
Alexion Pharmaceuticals
34 followers
Charles River Laboratories
11 followers
Cytiva
10 followers
Calico
6 followers
Merck
216 followers
AbbVie
178 followers
Explore companies